In vitro Testbed Platform for Evaluating Small Volume Contrast Agents via Magnetic Resonance Imaging

Perera-Gonzalez, Mireia; Kristine, Y.; Flask, Chris A.; Clark, Heather A.

doi:10.1109/dsd57027.2022.00082

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The decrease in acquisition time and potential for future translation towards clinical settings further emphasizes the importance of the development of these sequences at preclinical stages 76 . This platform would facilitate the analysis of sensors via in vitro MRI by reducing the impact of static field variations in the reproducibility of the measurements 110 , even at low volumes and concentrations 111 , therefore facilitating advancements in the field of MRI for chemical imaging 112,113 . Future studies can explore the use of more sophisticated phantoms as described by Keenan et al 95 , or directly image animal models.…”

Section: Discussionmentioning

confidence: 99%

Dynamic platform for magnetic resonance imaging of bioresponsive contrast agents

Perera Gonzalez

View full text Add to dashboard Cite

Magnetic Resonance Imaging (MRI) is a powerful non-invasive imaging modality with unlimited penetration depth, conventionally used for visualization of anatomical details. In efforts to better understand our bodies, there is an increasing interest to image chemical signatures in living systems with MRI. Research efforts have worked to overcome limitations of conventional MRI approaches, such as utilizing MRI contrast agents (CA) to improve molecular sensitivity and developing fast, quantitative methods with future potential for in vivo chemical imaging.Our research has focused on the optimization of a protocol to evaluate MRI CA, including hardware, experiment design, MRI data acquisition, and analysis. Here we proposed a reliable method for imaging small volume contrast agents in preclinical MRI scanners via a Microliter Scale Concentric (MiSCo) testbed as a hardware upgrade. We also demonstrated the success of MiSCo testbed to characterize pH-responsive MRI CA and help plan for translation towards ex vivo experiments in a rat brain model. To acquire dynamic data, we have engineered a Spiral Acquisition Matching Based Algorithm (SAMBA) for fast, quantitative preclinical imaging at low field strength (3T). Although spiral acquisitions and matching based algorithms are not novel, this work demonstrated how quantitative T1 and T2 spiral sequences paired with a dictionary matching-based algorithm provided in vitro results comparable to conventional approaches in a fraction of the scanning time. In addition, the insensitivity to motion artifacts characteristic of fingerprinting-like matching-based algorithms, demonstrated by Ma et al (2013), sets the stage for future in vivo work. This proposed platform for preclinical implementation serves as a foundation to image biochemical analytes in live animals in the near future, with the ultimate objective of unlocking the potential of MRI for chemical imaging of living systems.

show abstract

Section: Discussionmentioning

confidence: 99%

Dynamic platform for magnetic resonance imaging of bioresponsive contrast agents

Perera Gonzalez

View full text Add to dashboard Cite

show abstract

Fast Quantitative MRI: Spiral Acquisition Matching-Based Algorithm (Samba) for Robust T1 and T2 Mapping

Perera Gonzalez,

MacAskill,

Clark

et al. 2024

Preprint

View full text Add to dashboard Cite

In vitro Testbed Platform for Evaluating Small Volume Contrast Agents via Magnetic Resonance Imaging

Cited by 2 publications

References 19 publications

Dynamic platform for magnetic resonance imaging of bioresponsive contrast agents

Dynamic platform for magnetic resonance imaging of bioresponsive contrast agents

Fast Quantitative MRI: Spiral Acquisition Matching-Based Algorithm (Samba) for Robust T1 and T2 Mapping

Contact Info

Product

Resources

About